JPRN-UMIN000022779已完成未知
Clinical trial of the efficacy and safety of dydrogesterone in dysmenorrhoea patients. - Clinical trial of dydrogesterone in dysmenorrhoea patients.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 45years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Patients with medical history of serious liver failure or liver disease. 2.Patients with medical history of heart disease or kidney disease 3.Patients with porphyria. 4.Patients with medical history of peptic ulceration. 5.Patients with severe abnormal clinical examination. 6.Patients with asthma bronchial or asthma aspirin-sensitive. 7.Patients with colitis ulcerative or Crohn's disease. 8.Treatment with luteal hormone or follicular hormone-based hormone agents, low dose pill, middle dose pill, GnRH agonist, testosterone derivative, follicular hormone antagonist, aromatase inhibitor, Chinese herbal medicine for dysmenorrhea or within 2 months of initiation of administration 9.Treatment with transvaginal alcohol fixative, surgical therapy by laparotomy or laparoscope within 2 months of initiation of administration.
研究者
相似试验
已完成
不适用
The clinical study of the safety and efficacy of docetaxel combined with ribavirin in docetaxel resistant castration resistant prostate cancerProstate cancerJPRN-UMIN000015130Keio University School of Medicine, Department of Urology20
招募中
不适用
A clinical study to investigate the efficacy of diuretics to the HF patients with proteinuria and edema.Heart FailureJPRN-UMIN000006212Social Insurance Yokohama Central Hospital15
招募中
不适用
Prospective study on the clinical efficacy of Darolutamide in non-metastatic castration-resistant prostate cancerJPRN-UMIN000040914Department of Urology, Gunma University Graduate School of Medicine160
尚未招募
1 期
A clinical trial for the efficacy and safety of new Chinese herbal compound in reducing uric acid in patientsHyperuricemiaITMCTR2000003495Tongren of Traditional Chinese Medicine
招募中
3 期
Efficacy and safety of Dihydroartemisinine-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria, and chloroquine for Plasmodium vivax in Homalin (Sagaing Division), Lashio (Shan State) and Bokepyin (Tanintharyi Division).MalariaACTRN12614000214639Clinical Research Unit (malaria), Defense Services General Hospital200